The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus

Journal of the International Neuropsychological Society

Volumn 3, Issue 4, 1997, Pages 377-386

  Denburg, Susan D ^a,c   Carbotte, Ramona M ^a,b   Ginsberg, Jeffrey S ^a   Denburg, Judah A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Antiphospholipid antibodies; Cognitive function; Systemic lupus erythematosus

Indexed keywords

LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ARTICLE; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; VERBAL MEMORY;

EID: 0030806814     PISSN: 13556177     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1355617797003779     Document Type: Article

References (54)

1. Adelman, D.C., Saltiel, E., & Klinenberg, J.R. (1986). The neuropsychiatric manifestations of systemic lupus erythematosus: An overview. Seminars in Arthritis and Rheumatism, 15, 185-199.
2. Asherson, R.A., Khamashta, M.A., Gil, A., Vazquez, J.-J., Chan, O., Baguley, E., & Hughes, G.R.V. (1989). Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. American Journal of Medicine, 86, 391-399.
3. Bell, W.N. & Alton, H.G. (1954). A brain extract as a substitute for platelet suspension in the thromboplastin generation test. Nature, 174, 880-881.
4. Bluestein, H.G. (1992). The central nervous system in systemic lupus erythematosus. In R.G. Lahita (Ed.), Systemic lupus erythematosus (pp. 639-655). New York: Churchill Livingstone.
5. Brey, R.L., Arroyo, R., & Boswell, R.N. (1991). Cerebrospinal fluid anti-cardiolipin antibodies in patients with HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes, 4, 435-441.
6. Brey, R.L., Gharavi, A.E., & Lockshin, M.D. (1993). Neurologic complications of antiphospholipid antibodies. Rheumatic Disease Clinics of North America, 19, 833-850.
7. Bryden, M.P. (1982). Laterality: Functional asymmetry in the intact brain. Toronto, Ontario, Canada: Academic Press.
8. Burnstein, S.L., Janoff, L., & McCormick, K. (1987). Neuropsychiatric involvement in systemic lupus erythematosus: Case report and review of the literature. Journal of the American Osteopathic Association, 87, 626-631.
9. Carbotte, R.M., Denburg, S.D., & Denburg, J.A. (1986). Prevalence of cognitive impairment in systemic lupus erythematosus. Journal of Nervous and Mental Disease, 174, 357-364.
10. Carreras, L.O. & Vermylen, J. (1993). Anti-phospholipid antibodies and impairment of prostacyclin synthesis by the endothelium. In E.N. Harris, T. Exner, G.R.V. Hughes, & R.A. Asherson (Eds.), Phospholipid-binding antibodies (pp. 231-245). Boca Raton, FL: CRC Press.
11. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
12. Coull, B.M. & Goodnight, S.H. (1990). Antiphospholipid antibodies, prethrombotic states, and stroke. Stroke, 21, 1370-1374.
13. Denburg, J.A., Carbotte, R.M., & Denburg, S.D. (1987). Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology, 37, 464-467.
14. Denburg, S.D., Carbotte, R.M., & Denburg, J.A. (1987). Cognitive impairment in systemic lupus erythematosus: A neuropsychological study of individual and group deficits. Journal of Clinical and Experimental Neuropsychology, 9, 323-339.
15. Denburg, S.D., Denburg, J.A., Carbotte, R.M., Fisk, J.D., & Hanly, J.G. (1993). Cognitive deficits in systemic lupus erythematosus. Rheumatic Disease Clinics of North America, 19, 815-831.
16. Ginsberg, J.S., Demers, C., Brill-Edwards, P., Johnston, M., Bona, R., Burrows, R.F., Weitz, J., & Denburg, J.A. (1993). Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: Evidence for a prothrombotic state. Blood, 81, 2958-2963.
17. Ginsberg, J.S., Wells, P.S., Brill-Edwards, P., Donovan, D., Moffatt, K., Johnston, M., Stevens, P., & Hirsh, J. (1995). Antiphospholipid antibodies and venous thromboembolism. Blood, 86, 3685-3691.
18. Ginsburg, K.S., Wright, E.A., Larson, M.G., Fossel, A.H., Albert, M., Schur, P.H., & Liang, M.H. (1992). A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis and Rheumatism, 35, 776-782.
19. Gorman, D.G. & Cummings, J.L. (1993). Neurobehavioral presentations of the antiphospholipid antibody syndrome. Journal of Neuropsychiatry and Clinical Neurosciences, 5, 37-42.
20. Grant, I. & Heaton, R.K. (1990). Human immunodeficiency virus -type 1 (HIV-1) and the brain. Journal of Consulting and Clinical Psychology, 58, 22-30.
21. Grant, I., Olshen, R.A., Atkinson, J.H., Heaton, R.K., Nelson, J., McCutchan, J.A., & Weinrich, J.D. (1993). Depressed mood does not explain neuropsychological deficits in HIV-infected persons. Neuropsychology, 7, 53-61.
22. Hanly, J.G., Fisk, J.D., Sherwood, G., Jones, E., Jones, J.V., & Eastwood, B. (1992). Cognitive impairment in patients with systemic lupus erythematosus. Journal of Rheumatology, 19, 562-567.
23. Hay, E.M., Black, D., Huddy, A., Creed, F., Tomenson, B., Bernstein, R.M., & Holt, P.J.L. (1992). Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis and Rheumatism, 35, 411-416.
24. Heaton, R.K., Grant, I., Butters, N., White, D.A., Kirson, D., Atkinson, J.H., McCutchan, J.A., Taylor, M.J., Kelly, M.D., Ellis, R.J., Wolfson, T., Velin, R., Marcotte, T.D., Hesselink, J.R., Jernigan, T.L., Chandler, I, Wallace, M., Abramson, I., & HNRC Group. (1995). The HNRC 500-Neuropsychology of HIV infection at different disease stages. Journal of the International Neuropsychological Society, 1, 231-251.
25. Hughes, G.R.V. (1993). The antiphospholipid syndrome: Ten years on. Lancet, 342, 341-344.
26. Johnston, M. & Carter, C.J. (1983). The use of diagnostic algorithms for APTT inhibitors [Abstract]. IX International Congress on Thrombosis and Haemostasis, 846, 270.
27. Krupp, L.B., Masur, D.M., & Kaufman, L.D. (1993). Neurocognitive dysfunction in the eosinophilia-myalgia syndrome. Neurology, 43, 931-936.
28. Kutner, K.C., Busch, H.M., Mahmood, T., Racis, S.P., & Krey, P.R. (1988). Neuropsychological functioning in systemic lupus erythematosus. Neuropsychology, 2, 119-126.
29. Levine, S.R. & Welsh, K.M.A. (1987). The spectrum of neurologic disease associated with antiphospholipid antibodies: Lupus anticoagulants and anticardiolipin antibodies. Archives of Neurology, 44, 876-883.
30. Lezak, M.D. (1995). Neuropsychological assessment (3rd ed.). New York: Oxford University Press.
31. Long, A.A., Denburg, S.D., Carbotte, R.M., Singal, D.P., & Denburg, J.A. (1990). Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus. Annals of the Rheumatic Diseases, 49, 249-253.
32. Long, A.A., Ginsberg, J.S., Brill-Edwards, P., Johnston, M., Turner, C., Denburg, J.A., Bensen, W.G., Cividino, A., Andrew, M., & Hirsh, J. (1991). The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: A cross-sectional study. Thrombosis and Haemostasis, 66, 520-524.
33. Love, P.E. & Santoro, S.A. (1990). Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Annals of Internal Medicine, 112, 682-698.
34. Mackworth-Young, C.G., Loizou, S., & Walport, M.J. (1989). Antiphospholipid antibodies and disease. Quarterly Journal of Medicine, 72, 767-777.
35. Minden, S.L., Moes, E.J., Orav, I, Kaplan, E., & Reich, P. (1990). Memory impairment in multiple sclerosis. Journal of Clinical and Experimental Neuropsychology, 12, 566-586.
36. Papero, P.H., Bluestein, H.G., White, P., & Lipnick, R.N. (1990). Neuropsychologic deficits and antineuronal antibodies in pediatric systemic lupus erythematosus. Clinical and Experimental Rheumatology, 8, 417-424.
37. Proctor, R.R. & Rapaport, S.I. (1961). The partial thromboplastin time with kaolin. American Journal of Clinical Pathology, 36, 212-219.
38. Rao, S.M., Leo, G.J., & St.Aubin-Faubert, P. (1989). On the nature of memory disturbance in multiple sclerosis. Journal of Clinical and Experimental Neuropsychology, 11, 699-712.
39. Ryan, C.M., Morrow, L.A., Bromet, E.J., & Parkinson, D.K. (1987). The assessment of neuropsychological dysfunction in the work-place: Normative data from the Pittsburgh Occupational Exposures Test Battery. Journal of Clinical and Experimental Neuropsychology, 9, 665-679.
40. Sammaritano, L.R., Gharavi, A.E., & Lockshin, M.D. (1990). Antiphospholipid antibody syndrome: Immunologic and clinical aspects. Seminars in Arthritis and Rheumatism, 20, 81-96.
41. Schleider, M.A., Nachman, R.L., Jaffe, E.A., & Coleman, M. (1976). A clinical study of the lupus anticoagulant. Blood, 48, 499-509.
42. Skoraszewski, M.J., Ball, J.D., & Mikulka, P. (1991). Neuropsychological functioning of HIV-infected males. Journal of Clinical and Experimental Neuropsychology, 13, 278-290.
43. Stuss, D.T. & Cummings, J.L. (1990). Subcortical vascular dementias. In J.L. Cummings (Ed.), Subcortical dementia (pp. 145-163). New York: Oxford University Press.
44. Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, N.F., Schaller, J.G., Talal, N., & Winchester, R.J. (1982). The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism, 25, 1271-1277.
45. Tarter, R.E., Edwards, K.L., & Van Thiel, D.H. (1988). Perspective and rationale for neuropsychological assessment of medical disease. In R.E. Tarter, D.H. Van Thiel, & K.L. Edwards (Eds.), Medical neuropsychology: The impact of disease on behavior (pp. 1-10). New York: Plenum Press.
46. Thiagarajan, P., Pengo, V., & Shapiro, S.S. (1986). The use of the dilute Rüssel viper venom time for the diagnosis of lupus anti-coagulants. Blood, 68, 869-874.
47. Urowitz, M.B., Gladman, D.D., Tozman, E.C.S., & Goldsmith, C.H. (1984). The lupus activity criteria count (LACC). Journal of Rheumatology, 11, 783-787.
48. Wallace, D.J. & Metzger, A.L. (1993). Systemic lupus erythematosus and the nervous system. In D.J. Wallace & B.H. Hahn (Eds.), Dubois' lupus erythematosus (pp. 370-385). Philadelphia: Lea & Febiger.
49. Wallace, J.E., MacCrimmon, D.J., & Goldberg, W.M. (1980). Acute hyperthyroidism: Cognitive and emotional correlates. Journal of Abnormal Psychology, 89, 519-527.
50. Walsh, K.W. (1978). Neuropsychology: A clinical approach. New York: Churchill Livingstone.
51. Wechsler, D. (1945). A standardized memory scale for clinical use. Journal of Psychology, 19, 87-95.
52. Wechsler, D. (1955). Wechsler Adult Intelligence Scale. New York: The Psychological Corporation.
53. Wechsler, D. (1987). Wechsler Memory Scale-Revised. San Antonio, TX: The Psychological Corporation.
54. West, S.G. (1994). Neuropsychiatric lupus. Rheumatic Disease Clinics of North America, 20, 129-158.